“Small” Intestinal Immunopathology Plays a “Big” Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor
Immunology
[키워드] accompanied
administration
affected
antibodies
Antigen
blood pressure
bowel
caused
characterized
contribute
contributed
coronavirus disease
COVID-19
CRS
cytokine
cytokine production
Cytokine release syndrome
deficiency
Degradation
down-regulated
expression
Extracellular matrix
HLA class II transgenic mice
HLA-DR3
IFN-γ
IL-17A
immune
Immunopathogenesis
immunopathology
indicated
inflammatory pathway
inhibitor
inhibitors
intestinal
intestinal tissue
JAK inhibitor
janus
kinase
lethal
maintain
mice
Mortality
multiple organ
multiple organ dysfucntion
multiple organ dysfunction
organ
organ function
pathogenic
pathology
pathway
pro-apoptotic
receptor
Release
RNA sequencing
role
SARS-CoV-2
selective
severity
signaling pathway
significantly
significantly increased
specific treatment
staphylococcal
superantigens
Support
systemic level
T cell
T cell activation
therapy
Toxic shock syndrome
transgenic mice
Treatment
TSS
[DOI] 10.3389/fimmu.2020.01311 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.01311 PMC 바로가기 [Article Type] Immunology